TY  - GEN
AU  - Wadelius,M
AU  - Pirmohamed,M
TI  - Pharmacogenetics of warfarin: current status and future challenges
SN  - 1470-269X
PY  - 2007///0620
KW  - Anticoagulants
KW  - administration & dosage
KW  - Aryl Hydrocarbon Hydroxylases
KW  - genetics
KW  - Biotransformation
KW  - Cytochrome P-450 CYP2C9
KW  - Gene Expression Regulation, Enzymologic
KW  - Genetic Predisposition to Disease
KW  - Genotype
KW  - Hemorrhage
KW  - chemically induced
KW  - Humans
KW  - Liver
KW  - drug effects
KW  - Mixed Function Oxygenases
KW  - Patient Selection
KW  - Polymorphism, Single Nucleotide
KW  - Treatment Outcome
KW  - Vitamin K
KW  - antagonists & inhibitors
KW  - Vitamin K Epoxide Reductases
KW  - Warfarin
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.1038/sj.tpj.6500417
ER  -